Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients
[摘要] Background and objectives A dose-finding study was undertaken to investigate the efficacy of PA21, a novel polynuclear iron(III)-oxyhydroxide phosphate binder.
[发布日期] [发布机构]
[效力级别] [学科分类] 泌尿医学
[关键词] Bone marrow necrosis;Sickle cell disease;Hyperhemolysis syndrome [时效性]
